Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 3,816 | 5,930 | 10,073 | N/A |
| Marketable Securities | 25,264 | 31,471 | 1,504 | N/A |
| TOTAL | $29,505 | $38,239 | $11,743 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 52 | N/A | 1 | N/A |
| Investments And Advances | 539 | 9,486 | 0 | 0 |
| Other Non-Current Assets | 60 | 47 | 38 | 0 |
| TOTAL | $651 | $9,533 | $38 | $N/A |
| Total Assets | $30,156 | $47,772 | $11,781 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 549 | 550 | 322 | 0 |
| Accrued Expenses | 2,665 | 1,001 | 334 | N/A |
| Other current liabilities | 295 | 273 | N/A | N/A |
| TOTAL | $3,521 | $1,824 | $1,014 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 524 | 0 |
| TOTAL | $42 | $N/A | $524 | $N/A |
| Total Liabilities | $3,563 | $1,824 | $1,538 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 22,704 | 22,694 | N/A | N/A |
| Common Shares | 23 | 23 | 9 | N/A |
| Retained earnings | -73,565 | -53,472 | -37,937 | N/A |
| Other shareholders' equity | -879 | -1,964 | 39,190 | 0 |
| TOTAL | $26,593 | $45,948 | $10,243 | $N/A |
| Total Liabilities And Equity | $30,156 | $47,772 | $11,781 | $0 |